BEIJING--April 12, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--China's in vitro diagnostics (IVD) market revenue reached CNY124.3 billion (US$19.52 billion) in 2021, according to www.askci.com. The molecular diagnosis sector has grown strongly due to the COVID-19 pandemic, and the point-of-care testing (POCT) market has grown steadily for the past few years.
This Premium Article can be purchased individually or as part of a subscription
Subscription Type:
Articles related to this company